Trial Profile
Octreotide suppression test to diagnose thyrotropin-secreting pituitary adenoma and pituitary resistance to thyroid hormone.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Mar 2015
Price :
$35
*
At a glance
- Drugs Octreotide (Primary)
- Indications Pituitary adenoma; Pituitary disorders
- Focus Diagnostic use
- 02 Mar 2015 New trial record